معرفی
Dr. Luke Alderwick is an Honorary Senior Research Fellow in Biosciences at an unspecified university, actively accepting PhD students. His research focuses on the biochemistry and molecular genetics of cell wall assembly in Mycobacterium tuberculosis, particularly peptidoglycan (PG) biosynthesis and its recycling during dormancy, aiming to uncover mechanisms for novel TB therapies. He also explores non-canonical pathways in sodium iodide symporter (NIS) regulation for thyroid cancer recurrence prediction and enhanced radioiodide uptake.
In his recent publications, Alderwick investigates multidrug-resistant TB treatment through azetidine compounds and identifies novel Streptomyces strains with antimicrobial properties. His work spans biochemical analysis of mycobacterial enzymes to molecular targeting in oncology.
Alderwick collaborates on projects such as 'Inhibiting Staphylococcus aureus adhesion in atopic dermatitis' and 'A new mass spectrometer for structural proteomics,' funded by institutions like the British Skin Foundation, BBSRC, and MRC. His contributions highlight interdisciplinary expertise in combating infectious diseases and advancing cancer research.
